Related content

The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from nonsmallcell lung cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 116-120

Spandidos Publications

Access to resources Recommend Favorite

Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced nonsmallcell lung cancer: A case series of 20 patients

By                                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 454-460

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of erlotinib for previously treated patients with EGFR wildtype nonsmallcell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System

By                      

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 991-996

Spandidos Publications

Access to resources Recommend Favorite

Health resource utilisation associated with skeletalrelated events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 701-708

Spandidos Publications

Access to resources Recommend Favorite

ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

By  

The Journal Of Pathology: Clinical Research, Vol. 1, Iss. 3, 2015-06 ,pp. : 134-143

John Wiley & Sons Inc

Access to resources Recommend Favorite